openPR Logo
Press release

Poly Adenosine Diphosphate Ribose Polymerase Market Drivers

08-24-2018 04:05 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Poly Adenosine Diphosphate Ribose Polymerase Market Drivers

Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair of single stranded breaks in DNA that effectively destroys cancer cells.

These inhibitors play an effective role in current cancer-combating strategies, owing to its effectiveness in eliminating cancer cells as compared to the existing ovarian cancer treatments. Drugs such as Talazoparib and Veliparib that aid in treatment of ovarian cancer are in phase III clinical trials. Such research and development activities is a key factor contributing to the global poly adenosine diphosphate ribose polymerase market growth.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2029

High prevalence of various types of cancer is a key factor contributing to growth of the global poly adenosine diphosphate ribose polymerase market. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. According to American Cancer Society (ASC), around 22,240 women are expected to be diagnosed with ovarian cancer, and around 14,070 deaths are expected from the disease in 2018.

Furthermore, introduction of new drugs has propelled the poly adenosine diphosphate ribose polymerase market growth. For instance, the U.S. Food & Drug Administration approved 3 PARP inhibitors—Olaparib, Rucaparib, and Niraparib. These drugs are a potential alternative that aid in treatment of ovarian and other cancers after paclitaxel.

Moreover, combination of these PARP inhibitors with other therapies such as monoclonal antibodies is under research. For instance, in May 2018, TESARO, Inc.—an oncology-focused biopharmaceutical company— announced collaboration with Genentech—a member of the Roche Group—to evaluate the combination of the PD-L1 antibody— Atezolizumab (TECENTRIQ), the MEK inhibitor cobimetinib (COTELLIC), and TESARO’s PARP inhibitor ZEJULA (Niraparib) — in patients with platinum-sensitive ovarian cancer. In April 6, 2018, the U.S. Food and Drug Administration (FDA) approved Rubraca (rucaparib) tablets --manufactured by Clovis Oncology Inc.—for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients.

Moreover, robust pipeline of poly adenosine diphosphate ribose polymerase inhibitors is major factor contributing to the market growth over the forecast period. For instance, AbbVie’s and Pfizer Inc. have Veliparib and Talazoparib – in phase 3 clinical trials. Furthermore, these drugs are expected to be effective in the treatment of diseases other than ovarian cancer and the research for expanding indications is underway as well. For instance, Talazoparib developed by Pfizer Inc., is in phase 3 clinical trials for treatment of prostate cancer.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2029

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poly Adenosine Diphosphate Ribose Polymerase Market Drivers here

News-ID: 1200763 • Views: 149

More Releases from Coherent Market Insights

HIV Diagnostics Market Analysis, Growth with top Key players Abbott Healthcare, …
The HIV Diagnostics Market research provides complete estimation of CAGR of the concerned period in percentages which will guide the users to take choice-based decisions over the predicted chart. A thorough study of the competitive landscape of the global HIV Diagnostics has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT analysis. The HIV Diagnostics research report covers in-depth analysis of
Artificial Intelligence in Healthcare Market Qualitative Insights with top key p …
The Artificial Intelligence in Healthcare Market research provides complete estimation of CAGR of the concerned period in percentages which will guide the users to take choice-based decisions over the predicted chart. A thorough study of the competitive landscape of the global Artificial Intelligence in Healthcare has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT analysis. The Artificial Intelligence in Healthcare
Global Medical Adhesives & Sealants Market Professional Inspection Report with t …
The Global Medical Imaging Devices - Competitive Analysis Market research provides complete estimation of CAGR of the concerned period in percentages which will guide the users to take choice-based decisions over the predicted chart. A thorough study of the competitive landscape of the global Global Medical Imaging Devices - Competitive Analysis has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT
Women's Health Rehabilitation Products Market Potential growth, attractive valua …
The Women's Health Rehabilitation Products Market research provides complete estimation of CAGR of the concerned period in percentages which will guide the users to take choice-based decisions over the predicted chart. A thorough study of the competitive landscape of the global Women's Health Rehabilitation Products has been given, presenting insights into the company profiles, financial status, recent developments, mergers and acquisitions, and the SWOT analysis. The Women's Health Rehabilitation Products

All 5 Releases


More Releases for Poly

Poly Aluminum Chloride Market Foreseeable future of 2024
Poly aluminum chloride is present in liquid as well as solid form. In its powder version, it occurs as a yellow substance which must be packed in bags lined with polyethylene, whereas in its liquid form, it is colorless to pale yellow and needs to be packed in acid-resistant rubber or plastic-lined tanks or containers. Poly aluminum chloride, also known as poly aluminum chloride hydroxide sulphate and poly aluminum chloride
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair
Poly Trucks Market to Register Substantial Expansion by 2028
Though Industrial Automation Restricts Adoption, Emerging SMEs and Material Handling Industry Drive the Poly Trucks Market The market for poly trucks is expected to remain under the influence of growing industrial revolution and changing work demographics. Starting from storage to distribution, poly trucks are highly sought after as an important material handling asset. With the growth of manufacturing and warehousing industries, the demand for poly trucks is estimated to remain persistent
Poly Hydroxyalkanoate Market Analysis Report
The global Poly Hydroxyalkanoate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Detailed Report With TOC: https://www.reportsandmarkets.com/reports/global-and-japan-poly-hydroxyalkanoate-market-analysis-report-1532782 Japan plays an important role in the global market, with the market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of
Poly Hydroxyalkanoate Market Research Report 2017-2022
The global Poly hydroxyalkanoate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Detailed Report With TOC Here: https://www.reportsandmarkets.com/reports/global-poly-hydroxyalkanoate-market-research-report-types-applications-1532600 This report offers an overview of the market trends, drivers, and barriers with respect to the Polyhydroxyalkanoate market. It also provides a detailed overview of the market of different regions
Global Alcohol Poly Ethoxylates To boost industry
Alcohol Poly Ethoxylates Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Alcohol Poly Ethoxylates basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes;